Abiopharma

News list

Mosseri Marlio Charles 🟢 acquired 154.8K shares of Nuvectis Pharma, Inc. (NVCT) at $6.28 Transaction Date: Oct 23, 2025 | Filing ID: 103522

Full text

News bot Oct. 29, 2025, 12:01 p.m.
🔍 Mosseri Marlio Charles (Executive)

Company: Nuvectis Pharma, Inc. (NVCT)

Report Date: 2025-10-23
Transaction Summary:
- Total transactions: 4
- Derivative instruments: 0
- Holdings reported: 1
- Total shares acquired: 154,770
- Total shares held: 109,321
Detailed Transactions and Holdings:
- Acquired 46,900 shares of Common Stock at $6.06 per share (Direct)
  Date: 2025-10-23 | Code: P | equity_swap_involved: 0 | shares_owned_after: 3,028,706.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 35,034 shares of Common Stock at $6.15 per share (Direct)
  Date: 2025-10-24 | Code: P | equity_swap_involved: 0 | shares_owned_after: 3,063,740.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 72,836 shares of Common Stock at $6.28 per share (Direct)
  Date: 2025-10-27 | Code: P | equity_swap_involved: 0 | shares_owned_after: 3,136,576.00 | transaction_form_type: 4 | Footnotes: F1
- Holds 0 shares of Common Stock (Direct)
  Date: 2025-10-23 | Code: H | shares_owned_after: 109,321.00
Footnotes:
- F1: Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL SPF.